Is Pharmesis International (SGX:BFK) Using Too Much Debt?
Oct 10
Have your own idea? Try our Stock Screener
Singaporean (SGX) Pharma Industry Analysis
UpdatedOct 14, 2024
DataAggregated Company Financials
Companies4
- 7D-1.8%
- 3M3.3%
- 1Y7.5%
- YTD7.8%
Over the last 7 days, the Pharma industry has dropped 1.8%, driven by a pullback from Haw Par of 2.0%. In contrast, Pharmesis International has gained 22%. Over the past 12 months, the industry was up 7.5%. Looking forward, earnings are forecast to grow by 9.3% annually.
Industry Valuation and Performance
Has the Singaporean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 15 Oct 2024 | S$2.5b | S$448.3m | S$232.7m | 9.4x | 10.7x | 5.6x |
| Thu, 12 Sep 2024 | S$2.5b | S$448.2m | S$232.7m | 9.4x | 10.7x | 5.6x |
| Sat, 10 Aug 2024 | S$2.3b | S$431.9m | S$216.0m | 9.4x | 10.8x | 5.4x |
| Mon, 08 Jul 2024 | S$2.3b | S$431.9m | S$216.0m | 9.4x | 10.7x | 5.3x |
| Wed, 05 Jun 2024 | S$2.3b | S$432.0m | S$216.0m | 9.5x | 10.6x | 5.3x |
| Fri, 03 May 2024 | S$2.3b | S$417.3m | S$214.6m | 10x | 10.7x | 5.5x |
| Sun, 31 Mar 2024 | S$2.3b | S$417.2m | S$214.6m | 9.7x | 10.6x | 5.4x |
| Tue, 27 Feb 2024 | S$2.3b | S$371.2m | S$172.1m | 12.7x | 13.3x | 6.1x |
| Thu, 25 Jan 2024 | S$2.2b | S$371.1m | S$172.1m | 12.4x | 12.9x | 6x |
| Sat, 23 Dec 2023 | S$2.2b | S$371.0m | S$172.1m | 12.6x | 13x | 6x |
| Mon, 20 Nov 2023 | S$5.1b | S$1.5b | S$309.5m | 12.4x | 16.5x | 3.3x |
| Wed, 18 Oct 2023 | S$5.2b | S$1.5b | S$326.8m | 9.9x | 16x | 3.4x |
| Fri, 15 Sep 2023 | S$5.4b | S$1.5b | S$327.4m | 10.2x | 16.5x | 3.5x |
| Sun, 13 Aug 2023 | S$5.8b | S$1.5b | S$314.6m | 11.3x | 18.5x | 3.8x |
| Tue, 11 Jul 2023 | S$5.8b | S$1.5b | S$288.4m | 10.2x | 20.3x | 3.8x |
| Thu, 08 Jun 2023 | S$6.7b | S$1.5b | S$291.0m | 11x | 23x | 4.3x |
| Sat, 06 May 2023 | S$6.9b | S$1.6b | S$297.2m | 11.2x | 23.1x | 4.3x |
| Mon, 03 Apr 2023 | S$6.0b | S$1.6b | S$268.9m | 9.3x | 22.2x | 3.8x |
| Wed, 01 Mar 2023 | S$5.6b | S$1.4b | S$264.7m | 9.7x | 21.2x | 4.1x |
| Fri, 27 Jan 2023 | S$5.2b | S$1.4b | S$264.5m | 8.8x | 19.8x | 3.7x |
| Sun, 25 Dec 2022 | S$4.8b | S$1.4b | S$260.9m | 8.3x | 18.3x | 3.5x |
| Tue, 22 Nov 2022 | S$5.0b | S$1.4b | S$258.7m | 7.9x | 19.2x | 3.7x |
| Thu, 20 Oct 2022 | S$4.4b | S$1.3b | S$245.8m | 10.1x | 17.7x | 3.3x |
| Sat, 17 Sep 2022 | S$4.8b | S$1.3b | S$249.0m | 10.5x | 19.1x | 3.5x |
| Mon, 15 Aug 2022 | S$4.8b | S$1.4b | S$253.0m | 11x | 19x | 3.5x |
| Wed, 13 Jul 2022 | S$4.9b | S$1.3b | S$229.0m | 10.1x | 21.4x | 3.7x |
| Fri, 10 Jun 2022 | S$4.8b | S$1.3b | S$229.6m | 10.6x | 20.9x | 3.6x |
| Sun, 08 May 2022 | S$4.7b | S$1.3b | S$228.8m | 12.5x | 20.5x | 3.5x |
| Tue, 05 Apr 2022 | S$5.4b | S$1.4b | S$236.3m | 11.6x | 22.7x | 3.9x |
| Thu, 03 Mar 2022 | S$5.5b | S$1.4b | S$249.5m | 12.3x | 21.9x | 3.9x |
| Sat, 29 Jan 2022 | S$5.3b | S$1.3b | S$212.4m | 14.1x | 25.1x | 4x |
| Mon, 27 Dec 2021 | S$5.6b | S$1.3b | S$212.4m | 14.4x | 26.4x | 4.2x |
| Wed, 24 Nov 2021 | S$5.4b | S$1.3b | S$212.0m | 14x | 25.4x | 4x |
| Fri, 22 Oct 2021 | S$5.6b | S$1.3b | S$204.5m | 14.1x | 27.4x | 4.2x |
Price to Earnings Ratio
27.4x
Current Industry PE
- Investors are pessimistic on the Singaporean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 10.7x which is lower than its 3-year average PE of 18.3x.
- The 3-year average PS ratio of 4.3x is lower than the industry's current PS ratio of 5.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 4.5% per year over the last three years.
- Meanwhile revenues for these companies have declined 30% per year.
- This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.
Industry Trends
Which industries have driven the changes within the Singaporean Healthcare industry?
| SG Market | -0.62% | |
| Healthcare | -1.21% | |
| Pharma | -1.79% | |
| Pharma | -1.79% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BFK Pharmesis International | S$0.55 | 29.4% +S$4.0m | 358.3% | PS2.3x | |
| 1J5 Hyphens Pharma International | S$0.29 | 1.7% +S$1.5m | 5.4% | PE8.7x |
